Login
Boehringer Ingelheim
  • Therapeutic Area
    • Metabolic
  • Resources
  • Contact
Login

CV DEATH HAS A NEW OPPONENT
In patients with type 2 diabetes
with high CV risk

CV DEATH 
HAS A 
NEW OPPONENT

Jardiance® (Empagliflozin) is the only type 2 diabetes pill proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease
 
Close ×
  • Therapeutic Area
  • Metabolic
  • Resources
  • Videos
  • Clinical studies
  • Site map
  • Terms of use
  • Privacy
  • Contact
  • Change country

© 2010-2025
Boehringer Ingelheim International GmbH.
All rights reserved.